Argenx
ARGX
#422
Rank
โ‚น4.995 T
Marketcap
โ‚น80,221
Share price
-0.85%
Change (1 day)
55.07%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2025 (TTM): โ‚น83.60 Billion

According to Argenx 's latest financial reports the company's current earnings are โ‚น3.60 Billion. In 2024 the company made an earning of โ‚น7.65 Billion, an increase over its 2023 earnings that were of -โ‚น27.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น83.60 B992.71%
2024 โ‚น7.65 B-127.97%
2023 -โ‚น27.36 Billion-58.25%
2022 -โ‚น65.51 Billion
2019 -โ‚น17.87 Billion124.86%
2018 -โ‚น7.95 Billion131.81%
2017 -โ‚น3.43 Billion54.9%
2016 -โ‚น2.22 Billion33.71%
2015 -โ‚น1.66 Billion12.93%
2014 -โ‚น1.47 Billion46.39%
2013 -โ‚น1.01 Billion